Intelligence · Sponsor directory
Pharma & Biotech Companies
Premium sponsor intelligence profiles with pipeline dashboards, drug portfolios, patent hubs, and competitive peer analysis — built for BD, licensing, and research teams.
Quick answer
NovaPharmaNews profiles 1,769 pharmaceutical and biotech companies with SEC identifiers, headquarters, therapeutic focus, and cross-links to pipeline programs, drug portfolios, and US patents. Search by legal name, brand name, or ticker for BD, licensing, and competitive intelligence.
-
Herceptin
-
Hexal AG
-
Hikma Farmaceutica (Portugal)
Hikma Farmaceutica (Portugal) S.A.
-
Hiyasta
-
Holostem s.r.l
Holostem s.r.l.
-
Hospira UK
Hospira UK Limited
-
Huashan Hospital
-
Hudson Biotech
-
Humira
-
Hympavzi
-
I-Mab Biopharma US
I-Mab Biopharma US Limited
-
I.D.B. Radiopharmacy
I.D.B. Radiopharmacy B.V.
-
IDEA AG
-
INFAI
-
ITM Medical Isotopes
ITM Medical Isotopes GmbH
-
Idelvion
-
Idorsia Pharmaceuticals Deutschland
Idorsia Pharmaceuticals Deutschland GmbH
-
Ilaris
-
Imbruvica
-
Imfinzi
-
Immedica Netherlands
Immedica Netherlands B.V.
-
ImmuneOnco Biopharmaceuticals (Shanghai)
-
Immunomedics
Immunomedics GmbH
-
Impact Therapeutics
Frequently asked questions
What is the NovaPharmaNews companies directory?
It is a searchable index of 1,769 pharma and biotech organizations — public and private — with ticker symbols, HQ location, company type, and counts of linked pipeline programs, drugs, and patents.
Where does company data come from?
Profiles combine SEC EDGAR filings, ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page for attribution and refresh cadence. Directory content is for professional reference, not investment advice.
How do I find a company by ticker or name?
Use the search box — it matches legal name, common name, and stock ticker. Each company profile links to its pipeline programs, marketed drugs, and related patents where available.